TCM
GMVD

Tradewinds Capital Management’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Tradewinds Capital Management’s Portfolio GMVD Stock Details GMVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,392
Closed -$62K – 846
2022
Q1 		$62K Buy
1,392
+821
+144% +$80.3K 0.01% 228
2021
Q4 		$33K Sell
571
-29
-5% -$2.16K 0.01% 309
2021
Q3 		$47K Buy
+600
New +$63.3K 0.01% 254

Other funds holding GMVD

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Tradewinds Capital Management's GMVD Position: Q2 2022 in Review

Tradewinds Capital Management sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q2 2022, closing a stake of 1,392 shares — an estimated $62K sold.

Tradewinds Capital Management first reported a position in GMVD in Q3 2021 and held it in 3 quarters. The position peaked at $62K in Q1 2022. 14 funds tracked by Wall St. Rank hold GMVD as of Q2 2022.

  • Tradewinds Capital Management reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 1,392 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q2 2022, an estimated $62K.
  • Tradewinds Capital Management first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • Tradewinds Capital Management's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $62K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q2 2022.

Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.